Serena Travaglini | Genetics and Molecular Biology | Best Researcher Award

Published on by Invention Awards

Dr. Serena Travaglini | Genetics and Molecular Biology | Best Researcher Award

Dr. Serena Travaglini | University of Rome Tor Vergata  | Italy

Dr. Serena Travaglini is a dedicated molecular biologist and researcher at the University of Rome “Tor Vergata” specializing in the characterization of leukemia stem cells. Born in Rome, she advanced through a strong academic trajectory in biotechnology, earning bachelor’s, master’s, and doctoral degrees from Tor Vergata University. She conducted her doctoral research under leading mentors, focusing on FLT3-ITD-mutated acute myeloid leukemia, identifying novel therapeutic targets. After completing her doctorate, she deepened her expertise in postdoctoral studies exploring CD99 as a therapeutic marker and the transcriptomic evolution of AML. Currently, she leads investigations into the role of p63 in thymoma within the Laboratory of Biochemistry and Molecular Biology. With a solid foundation in molecular biotechnology and translational medicine, Dr. Travaglini exemplifies excellence in both research innovation and academic leadership.

Profiles

Scopus
Orcid

Education and Experience

Dr. Travaglini’s academic journey reflects sustained dedication to biotechnology and translational medicine. She graduated in biotechnology and advanced to earn a master’s in medical biotechnology, followed by a PhD in biotechnology and translational medicine, all at Tor Vergata University. Her early research explored oxidative stress in neurodegenerative diseases and the molecular interplay in APL. During her doctoral studies, she investigated FLT3-ITD-mutated leukemia stem cells, pursuing actionable targets to impede relapse. Her postdoctoral work further expanded her expertise by analyzing CD99’s role in leukemic progenitor cell behavior and homing. As a researcher, she now explores p63’s involvement in thymoma, integrating molecular insights with translational goals. Her progression reflects a consistent focus on dissecting leukemic pathophysiology to inform therapeutic strategies.

Research Interests

Dr. Travaglini’s research spans the genetic and cellular characterization of leukemia, with a distinctive focus on leukemia stem cells and clonal evolution. She is deeply interested in validating genetic biomarkers in AML and APL, exploring therapeutic vulnerabilities, and understanding resistance in arsenic-trioxide-treated APL. Her work includes analysis of surface immunophenotypes including CD99, CD34, and CD123, and characterizing t(11;17)-positive AMLs. She also investigates therapy-related AML and how genetic changes drive disease progression. Her broader goals emphasize leveraging multiparameter flow cytometry, genetics, and in vivo modeling to inform precision medicine strategies that combat recurrence and treatment resistance.

Awards & Recognition

Dr. Travaglini is the recipient of notable recognitions for her contributions to life sciences research. She received the Angeletti-Mortari Life Sciences Research Prize from MSD Italia—an award honoring innovation by emerging researchers and supporting their work in scientific excellence within Italy. She also won the “AIL Beat Leukemia” Fellowship awarded by the Italian Society of Experimental Hematology, which advanced her project investigating the molecular landscape of high-risk acute promyelocytic leukemia and strategies to overcome disease progression beat-leukemia.org. These honors reflect her impactful contributions to leukemia research and her promise as a leading young scientist.

Publications Top Notes

Functional characterization and response to FLT3 inhibitors in acute myeloid leukaemia with a non‐canonical FLT3 mutation: A proof of concept

Journal: British Journal of Haematology
Authors: Serena Travaglini, Carmelo Gurnari, Silvia Antonelli, Francesco Marchesi, Gioia De Angelis, Tiziana Ottone, Mariadomenica Divona, Antonio Cristiano, Hajro Hajrullaj, Andrea Mengarelli, et al.

Ascorbate Plus Buformin in AML: A Metabolic Targeted Treatment

Journal:  Cancers 
Authors: Cristina Banella, Gianfranco Catalano, Serena Travaglini, Elvira Pelosi, Tiziana Ottone, Alessandra Zaza, Gisella Guerrera, Daniela Francesca Angelini, Pasquale Niscola, Mariadomenica Divona, et al.

From Clonal Hematopoiesis to Therapy-Related Myeloid Neoplasms: The Silent Way of Cancer Progression

Journal: Biology 
Authors: Carmelo Gurnari, Emiliano Fabiani, Giulia Falconi, Serena Travaglini, Tiziana Ottone, Antonio Cristiano, Maria Teresa Voso.

PML/RARa Interferes with NRF2 Transcriptional Activity Increasing the Sensitivity to Ascorbate of Acute Promyelocytic Leukemia Cells

Journal: Cancers 
Authors: Cristina Banella, Gianfranco Catalano, Serena Travaglini, Mariadomenica Divona, Silvia Masciarelli, Gisella Guerrera, Francesco Fazi, Francesco Lo-Coco, Maria Teresa Voso, Nelida Ines Noguera.

Conclusion

Dr. Serena Travaglini stands as a distinguished emerging researcher in molecular hematology, demonstrating both scientific rigor and translational vision. Her academic excellence, from her foundational training through her innovative postdoctoral and current work, underscores her commitment to unraveling the biological mechanisms underpinning leukemia and resistance. Her strategically focused research on leukemia stem cells, therapeutic biomarker validation, and overcoming drug-resistant APL speaks to her potential to influence next-generation leukemia therapies. Recognition through prestigious awards and notable scholarly contributions further affirm her candidacy. With continued support, Dr. Travaglini is poised to lead impactful research initiatives that can reshape treatment paradigms in acute leukemia and precision medicine.

Subhrangshu Das | Bioinformatics | Best Researcher Award

Published on by Invention Awards

🌟Mr. Subhrangshu Das, Bioinformatics, Best Researcher Award🏆

Subhrangshu Das at CSIR-Indian Institute of Chemical Biology, India

Subhrangshu Das is a highly qualified individual with a diverse academic background and extensive experience in both computer science and structural biology/bioinformatics. He holds a B.Tech. in Computer Science & Engineering, an M.E. in Computer Science & Engineering, and is on the verge of completing his Ph.D. in Structural Biology and Bioinformatics. Throughout his career, Das has demonstrated a keen interest in interdisciplinary research, utilizing his expertise in computer science to contribute to the field of biology.

Author Metrics:

Google Scholar Profile

Scopus Profile

Das has an impressive publication record, with several articles published in reputable scientific journals. His research contributions span topics such as Alzheimer’s disease detection, protein-protein interaction interface prediction, and sub-cellular organelle analysis. He has also presented his work at conferences and workshops, further showcasing his expertise and involvement in the scientific community.

Citations: 115 citations by 110 documents.

Documents: 9 documents authored.

h-index: 6. The h-index is a metric that attempts to measure both the productivity and citation impact of the publications of a scientist or scholar. An h-index of 6 means the author has at least 6 papers that have been cited at least 6 times each.

Education:

Das’s educational journey includes a Bachelor of Technology in Computer Science & Engineering, a Master of Engineering in Computer Science & Engineering, and a pending Ph.D. in Structural Biology and Bioinformatics. His academic achievements demonstrate a strong foundation in both computer science and biological sciences, providing him with a unique skill set for interdisciplinary research.

Research Focus:

Das’s research focuses on the intersection of computer science and biology, particularly in the areas of structural biology and bioinformatics. His work involves the development and application of computational algorithms and techniques for analyzing biological data, with specific emphasis on Alzheimer’s disease detection, protein-protein interaction interface prediction, and sub-cellular organelle analysis.

Professional Journey:

Das has a rich professional journey, starting as a Junior Research Fellow and progressing to the role of Senior Research Fellow before becoming a Research Associate at CSIR – Indian Institute of Chemical Biology. Throughout his career, he has been actively involved in research projects, contributing to advancements in structural biology and bioinformatics.

Honors & Awards:

Das has received several honors and awards for his academic and research achievements. Notable accolades include qualifying in GATE and CSIR NET exams, as well as receiving scholarships during his Master’s and Ph.D. studies. These recognitions underscore his dedication and excellence in both academic and research endeavors.

Publications Noted & Contributions:

Das has made significant contributions to the scientific community through his publications in reputable journals. His research on Alzheimer’s disease detection, protein-protein interaction interface prediction, and sub-cellular organelle analysis has advanced our understanding of these complex biological processes. Additionally, his presentations at conferences and workshops have disseminated valuable insights to the scientific community.

Title: CMT2A‐linked mitochondrial hyperfusion‐driving mutant MFN2 perturbs ER‐mitochondrial associations and Ca2+ homeostasis

  • Authors: R. Das, S. Das, S. Chakrabarti, O. Chakrabarti
  • Journal: Biology of the Cell
  • Volume/Issue: 114 (11)
  • Pages: 309-319
  • Year: 2022
  • Citations: 4

Title: Three Dimensional Face Registration by Pose Orientation and Recognition using PCA

  • Author: S. Das
  • Year: 2014
  • Citations: 1
  • Title: CCADD: An Online Webserver for Alzheimer’s Disease Detection from Brain MRI
  • Authors: P. Panigrahi, S. Das, S. Chakrabarti
  • Journal: Computers in Biology and Medicine
  • Article Number: 108622
  • Year: 2024

Title: SARS-CoV-2: From Genetic Variability to Vaccine Design

  • Authors: Nupur Biswas*, Krishna Kumar, Priyanka Mallick, Subhrangshu Das, Izaz Monir Kamal, Sarpita Bose, Anindita Choudhury, Saikat Chakrabarti
  • Editors: I. Saha, W.H. Chen
  • Publisher: Springer
  • Year: 2022

Title: Structural and Drug Screening Analysis of the Non-structural Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 Virus Extracted From Indian Coronavirus Disease 2019

  • Authors: N. Biswas, K. Kumar, P. Mallick, S. Das, I.M. Kamal, S. Bose, A. Choudhury, …
  • Journal: Frontiers in Genetics
  • Article Number: 171

Research Timeline:

Das’s research timeline spans his academic journey from his Bachelor’s degree to his current role as a Ph.D. candidate. Throughout this timeline, he has been actively engaged in research projects, focusing on various aspects of structural biology and bioinformatics. His progression from a Junior Research Fellow to a Research Associate reflects his growth and expertise in the field.

Collaborations and Projects:

Das has been involved in numerous research projects, collaborating with fellow scientists and researchers to address key challenges in structural biology and bioinformatics. His projects have encompassed diverse topics such as Alzheimer’s disease detection, stroke quantification, protein-protein interaction interface prediction, and sub-cellular organelle analysis. Through these collaborations, Das has contributed to interdisciplinary research efforts and fostered innovation in the field.